PMC4819267_01
MRI of the right shoulder showing the tumor extent at the time of initial diagnosis in proton density (PD)-weighted (a) and T1-weighted contrast-enhanced (b) sequences. An inhomogeneously enhancing, partially fibrotic tumor (white arrows) originating from the right thoracic wall is clearly visible consistent with a desmoid-type fibromatosis
13569_2016_45_Fig1_HTML.jpg
PMC4819267_01_13569_2016_45_Fig1_HTML.jpg
Fig1
We report on a case of a 16-year old male patient who was diagnosed with DF of the right upper thorax in 2011 (Fig. 1).
T2-weighted MRI of the right shoulder after second tumor resection and prior to bevacizumab treatment (a), as well as 6 weeks (b), 4 months (c) and 14 months (d) after treatment initiation, showing a continuous tumor shrinkage over time (white arrows)
13569_2016_45_Fig2_HTML.jpg
PMC4819267_01_13569_2016_45_Fig2_HTML.jpg
Fig2
Treatment was continued for a total duration of 12 months with a further decrease in tumor diameter of 38 % (Fig. 2).